4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with pargyline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, HH; Wachtel, H | 1 |
1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and pargyline
| Article | Year |
|---|---|
Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; alpha-Methyltyrosine; Animals; Antidepressive Agents; Biogenic Amines; Body Temperature; Fenclonine; Imipramine; Male; Methyltyrosines; Mice; Motor Activity; Pargyline; Phosphodiesterase Inhibitors; Pyrimidines; Pyrrolidinones; Reserpine; Rolipram | 1986 |